TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
27 hedge funds and large institutions have $54M invested in Trillium Therapeutics Inc. in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $53.1M → $54M (+$966K)
Holders
27
Holding in Top 10
1
Calls
$122K
Puts
$96K
Top Buyers
| 1 | +$1.25M | |
| 2 | +$779K | |
| 3 | +$569K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$515K |
| 5 |
Morgan Stanley
New York
|
+$468K |
Top Sellers
| 1 | -$830K | |
| 2 | -$682K | |
| 3 | -$193K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$180K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$165K |